誠實的德國藥物管理者 被移離職位 儘管醫生抗議
Honest German drug regulator removed from position in spite of doctors' protests
Monday, 25 January 2010 15:28
News - Highlighted News
Peter Sawicki, the head of the German government drug regulator IQWiG who insisted on adequate safety and financial data before approving drugs, will not have his contract renewed when it runs out in August 2010, reports Der Spiegel.
德國政府和藥物管理局IQWiG頭頭Sawicki，他堅持在批准藥物之前，要有足夠的安全和財務數據，在2010年8月合同到期時，一直不獲更新合約，報告明鏡。
Sawicki enjoyed strong support from doctors for his science- and evidence-based approach to approving drugs: 600 doctors in Germany signed a letter asking for him to be kept in his position.
Sawicki得到強勁的醫生們支持，為他的科學和證據為基礎的做法去審批藥品：600名在德國的醫生簽署了一封信，為他要求被保留在他的職位。
However, Sawicki has come under fierce criticism from the pharmaceutical companies for his stance.
然而，Sawicki因為他的立場，已遭受到來自製藥公司的激烈批評。
The ruling government coalition of CDU/CSU and FDP has pushed for his removal.
Sawicki’s contract was ostensibly not renewed because of irregularities with concerning his company car, but Der Spiegel reports that Sawicki has complied with all the conditions of the IQWiG company car contract, and suggests he is suffering being discredited and punished as a result of his refusal to approve potentially dangerous drugs.
The decision to remove Sawicki will raise fears that the profits of pharmaceutical companies are being put before the health of the general public, and that the politicans see big pharma as their "clients" to be pleased.
SPIEGEL ONLINE
21. Januar 2010, 20:43 Uhr
IQWiG-Chef Sawicki
Oberster Arzneimittelprüfer muss gehen
Von Veronika Hackenbroch und Katrin Elger
Der Krimi um IQWiG-Chef Peter Sawicki ist zu Ende: Nach....
......... IQWiG."
Inzwischen hat sogar das renommierte Fachblatt "Science" über den Fall Sawicki berichtet. Die Überschrift: " Unter feindlichem Beschuss der Pharmaindustrie".
http://www.theflucase.com/index.php?option=com_content&view=article&id=2629%3Ahonest-german-drug-regulator-removed-from-position-in-spite-of-doctors-protests&catid=41%3Ahighlighted-news&Itemid=105&lang=en
沒有留言:
發佈留言